Cargando…

Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for Use in Patients With Pulmonary Arterial Hypertension

BACKGROUND: Achievement of low-risk status is a treatment goal in pulmonary arterial hypertension (PAH). Risk assessment often is performed using multiparameter tools, such as the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL) risk calculator. Risk calculators that assess f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benza, Raymond L., Kanwar, Manreet K., Raina, Amresh, Scott, Jacqueline V., Zhao, Carol L., Selej, Mona, Elliott, C. Greg, Farber, Harrison W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Inc under license from the American College of Chest Physicians. 2021
Materias:	Pulmonary and Cardiovascular: Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462639/ https://www.ncbi.nlm.nih.gov/pubmed/32882243 http://dx.doi.org/10.1016/j.chest.2020.08.2069

Ejemplares similares

Data on clinical and economic burden associated with pulmonary arterial hypertension related hospitalizations in the United States
por: Chaturvedi, Abhishek, et al.
Publicado: (2020)

Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension
por: Raina, Amresh, et al.
Publicado: (2013)

Replacing a phosphodiesterase-5 inhibitor with riociguat in patients with connective tissue disease-associated pulmonary arterial hypertension: a case series
por: Raina, Amresh, et al.
Publicado: (2017)

Risk assessment in patients with functional class II pulmonary arterial hypertension: Comparison of physician gestalt with ESC/ERS and the REVEAL 2.0 risk score
por: Sahay, Sandeep, et al.
Publicado: (2020)

Switching to riociguat: a potential treatment strategy for the management of CTEPH and PAH
por: Benza, Raymond L., et al.
Publicado: (2020)

Electronic pulmonary embolism clinical decision support and effect on yield of computerized tomographic pulmonary angiography: ePE—A pragmatic prospective cohort study
por: Bledsoe, Joseph R., et al.
Publicado: (2021)

The Mistaken Birth and Adoption of LNT: An Abridged Version
por: Calabrese, Edward J.
Publicado: (2017)

Confirmatory psychometric evaluations of the Impact of Weight on Quality of Life–Lite Clinical Trials Version (IWQOL‐Lite‐CT)
por: Kolotkin, Ronette L., et al.
Publicado: (2021)

Validation of the Wisconsin upper respiratory symptom survey-24, Chinese version
por: Wang, Yuanyuan, et al.
Publicado: (2022)

Work Climate Scale in Emergency Services: Abridged Version
por: Lozano-Lozano, José Antonio, et al.
Publicado: (2021)

Does Tracheostomy Improve Outcomes in Those Receiving Venovenous Extracorporeal Membrane Oxygenation?
por: Boudreaux, Joel C., et al.
Publicado: (2023)

Development of a clinical trials version of the Impact of Weight on Quality of Life‐Lite questionnaire (IWQOL‐Lite Clinical Trials Version): results from two qualitative studies
por: Kolotkin, R. L., et al.
Publicado: (2017)

Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?
por: Vizza, Carmine Dario, et al.
Publicado: (2021)

Cryptogenic stroke and patent foramen ovale (abridged and translated version)
por: Diener, Hans-Christoph, et al.
Publicado: (2019)

GLIMMPSE Lite: Calculating Power and Sample Size on Smartphone Devices
por: Munjal, Aarti, et al.
Publicado: (2014)

Cannula Design and Recirculation During Venovenous Extracorporeal Membrane Oxygenation
por: Palmér, Oscar, et al.
Publicado: (2016)

S100A4 amplifies TGF-β-induced epithelial–mesenchymal transition in a pleural mesothelial cell line
por: Ning, Qian, et al.
Publicado: (2018)

A primer on proning in the emergency department
por: McGurk, Kevin, et al.
Publicado: (2020)

The Effect of Additional Stepwise Venous Inflow on Differential Hypoxia of Veno-Arterial Extracorporeal Membrane Oxygenation
por: Lee, Jin Gu, et al.
Publicado: (2019)

Redox regulation of motile cilia in airway disease
por: Price, Michael E., et al.
Publicado: (2019)

Evaluation of Recirculation During Venovenous Extracorporeal Membrane Oxygenation Using Computational Fluid Dynamics Incorporating Fluid-Structure Interaction
por: Conrad, Steven A., et al.
Publicado: (2020)

A clinical decision framework to guide the outpatient treatment of emergency department patients diagnosed with acute pulmonary embolism or deep vein thrombosis: Results from a multidisciplinary consensus panel
por: Kabrhel, Christopher, et al.
Publicado: (2021)

Multilayer Scaling of a Biomimetic Microfluidic Oxygenator
por: Vedula, Else M., et al.
Publicado: (2022)

Neuromuscular blocking agents for acute respiratory distress syndrome
por: Torbic, Heather, et al.
Publicado: (2019)

Recruitment manoeuvres for adults with acute respiratory distress syndrome receiving mechanical ventilation: a systematic review and meta-analysis
por: Kang, Hanyujie, et al.
Publicado: (2019)

Long-Term Physical, Cognitive, and Psychological Outcomes in Severe COVID-19 Patients Managed With Extracorporeal Membrane Oxygenation: A Prospective Study
por: Pozzi, Matteo, et al.
Publicado: (2023)

Hemothorax after sneezing
por: Neff, Andrew, et al.
Publicado: (2023)

Disposition of emergency department patients with acute pulmonary embolism after ambulance arrival
por: Rouleau, Samuel G., et al.
Publicado: (2023)

Safety and efficacy of transitioning from the combination of bosentan and sildenafil to alternative therapy in patients with pulmonary arterial hypertension
por: Verlinden, Nathan J., et al.
Publicado: (2020)

The Construction and Validation of an Abridged Version of the Autism-Spectrum Quotient (AQ-Short)
por: Hoekstra, Rosa A., et al.
Publicado: (2010)

Abridged Therapeutics
Publicado: (1882)

Susceptibility of Patients with Airway Disease to SARS-CoV-2 Infection
por: Conway, Francesca M., et al.
Publicado: (2022)

Cultural Adaptation and Validation of the Portuguese Version of the CANHELP Lite Bereavement Questionnaire
por: Pereira, Alexandra, et al.
Publicado: (2020)

Phosphodiesterase type 5 inhibitor to riociguat transition is associated with hemodynamic and symptomatic improvement in pulmonary hypertension
por: Davey, Ryan, et al.
Publicado: (2017)

E‐REVEAL Lite 2.0 scoring for early prediction of disease progression in pulmonary arterial hypertension
por: Sahay, Sandeep, et al.
Publicado: (2022)

S1 guidelines “lumbar puncture and cerebrospinal fluid analysis” (abridged and translated version)
por: Tumani, H., et al.
Publicado: (2020)

Guidelines for Central Venous Port Placement and Management (Abridged Translation of the Japanese Version)
por: Sugawara, Shunsuke, et al.
Publicado: (2023)

Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)
por: Preston, Ioana R., et al.
Publicado: (2015)

Abridging CMOS Technology
por: Wong, Hei
Publicado: (2022)

EVALUATION OF LUNG FUNCTION AFTER SARS-COV-2 PNEUMONIA
por: ORZES, NICLA, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aihfmlhmv86q9flvc35jtakha2